Clinical Trial Update: DFT383 in Pediatric Participants With Nephropathic Cystinosis [Phase 1, Phase 2]

View source ↗

Summary

DFT383 is being studied in pediatric participants with nephropathic cystinosis in Phase 1/2 trials. The study is currently recruiting, sponsored by Novartis Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathic Cystinosis

Drugs mentioned

• DFT383

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Nephropathic Cystinosis | Phase 1, Phase 2 | Status: RECRUITING